Kracov Quoted in Bloomberg BNA on FDA's Potential Expansion of Generic Drug Access

June 23, 2017

Life Sciences and Healthcare Regulatory co-chair and partner Dan Kracov was quoted in a recent Bloomberg BNA article, "Grassley, FDA Focus on Increasing Generic Drug Competition," which discusses the pricing practices and rules governing entry to the generic drug market used by drugmakers.

ยป Read the full article (subscription required).

Email Disclaimer